Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$164.13
-0.09%
Mkt Cap $24.86B
Analyst Ratings
Buy
7
Hold
6
Sell
2
Price Target (64 analysts)
$147.13
Range $110.00 – $170.00
Implied Upside
-10.4%
Consensus $147.13 vs current $164.13